Retraction: Inhibition of endothelial cell proliferation and tumor angiogenesis by upregulating ndrg2 expression in breast cancer cells (PLoS ONE (2012) 7: 2 (e32368) DOI: 10.1371/journal.pone.0032368);Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating ndrg2 expression in breast cancer cells

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Ma, Ji ^a,b,c   Liu, Wenchao ^a   Yan, Xiaohong ^d   Wang, Qianrong ^a   Zhao, Qingli ^c   Xue, Yan ^a   Ren, Hui ^c   Wu, Lin ^b   Cheng, Yuanxiong ^e   Li, Sen ^a   Miao, Lu ^b   Yao, Libo ^b   Zhang, Jian ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c LANZHOU GENERAL HOSPITAL   (China)

^d Baoji Central Hospital   (China)

^e SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BETA GALACTOSIDASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; N MYC DOWNSTREAM REGULATED PROTEIN 2; PROTEIN P53; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC GENE THERAPY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; CANCER INVASION; CANCER TRANSPLANTATION; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIUM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; TUMOR CELL LINE; UPREGULATION;

ADENOVIRIDAE; MUS MUSCULUS;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; UP-REGULATION;

EID: 84863276707     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0240574     Document Type: Erratum

References (25)

1. Munoz-Najar UM, Neurath KM, Vumbaca F, Claffey KP, (2006) Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25: 2379-2392.
2. Yang XM, Wang YS, Zhang J, Li Y, Xu JF, et al. (2009) Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci 50: 1873-1879.
3. Dewhirst MW, (2009) Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress. Radiat Res 172: 653-665.
4. Wang YQ, Luk JM, Ikeda K, Man K, Chu AC, et al. (2004) Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. Biochem Biophys Res Commun 317: 358-362.
5. Sikora S, Godzik A, (2004) Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction-the case of VHL (von Hippel-Lindau) protein and angiogenesis regulatory pathway. Protein Sci 13: 786-796.
6. Chen D, Li M, Luo J, Gu W, (2003) Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 278: 13595-13598.
7. Pal S, Datta K, Mukhopadhyay D, (2001) Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res 61: 6952-6957.
8. Deng Y, Yao L, Chau L, Ng SS, Peng Y, et al. (2003) N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 106: 342-347.
9. Zhou RH, Kokame K, Tsukamoto Y, Yutani C, Kato H, et al. (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73: 86-97.
10. Yao L, Zhang J, Liu X, (2008) NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin (Shanghai) 40: 625-635.
11. Zhang J, Li F, Liu X, Shen L, Liu J, et al. (2006) The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Biol Chem 281: 39159-39168.
12. Gao L, Wu GJ, Liu XW, Zhang R, Yu L, et al. (2011) Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene. Cancer Lett 310: 94-100.
13. Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C, (2011) Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer. BMC Cancer 11: 14.
14. Liu N, Wang L, Liu X, Yang Q, Zhang J, et al. (2007) Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. Biochem Biophys Res Commun 358: 164-169.
15. Shon SK, Kim A, Kim JY, Kim KI, Yang Y, et al. (2009) Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun 385: 198-203.
16. Zheng J, Liu Q, Li Y, Yang J, Ma J, et al. (2010) NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells. Asian Pac J Cancer Prev 11: 1817-1821.
17. Choi SC, Yoon SR, Park YP, Song EY, Kim JW, et al. (2007) Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med 39: 705-714.
18. Wang L, Liu N, Yao L, Li F, Zhang J, et al. (2008) NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells. Cell Physiol Biochem 21: 239-250.
19. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, et al. (2000) Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev 14: 34-44.
20. Nor JE, Christensen J, Mooney DJ, Polverini PJ, (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384.
21. Krieg M, Haas R, Brauch H, Acker T, Flamme I, et al. (2000) Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function. Oncogene 19: 5435-5443.
22. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND, et al. (2000) Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19: 4621-4631.
23. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, et al. (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273: 11995-11998.
24. Pille JY, Denoyelle C, Varet J, Bertrand JR, Soria J, et al. (2005) Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther 11: 267-274.
25. Zheng J, Li Y, Yang J, Liu Q, Shi M, et al. (2011) NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer 11: 251: 251-259.